Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 835

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 835
---
 |   | ​ |
|:------------------------------------|:--|:--|:------------------|:--|-------:|:--|:--|:--|:------------------|:--|-------:|:--|:--|
| Accounts payable                    | ​ | ​ | ​                 | $ | 11,583 | ​ | ​ | ​ | ​                 | $ |  9,604 | ​ | ​ |
| Accrued research projects           | ​ | ​ | ​                 | ​ |  4,343 | ​ | ​ | ​ | ​                 | ​ |  5,200 | ​ | ​ |
| Accrued compensation and benefits   | ​ | ​ | ​                 | ​ |  6,519 | ​ | ​ | ​ | ​                 | ​ |  5,219 | ​ | ​ |
| Accrued professional fees and other | ​ | ​ | ​                 | ​ |  3,147 | ​ | ​ | ​ | ​                 | ​ |  1,517 | ​ | ​ |
| Total                               | ​ | ​ | ​                 | $ | 25,592 | ​ | ​ | ​ | ​                 | $ | 21,540 | ​ | ​ |

10. Royalty Purchase and Sale Agreement During the fourth quarter of 2023, the Company, through its wholly-owned subsidiary Cara Royalty Sub, LLC, a Delaware limited liability company, or Cara Royalty Sub, entered into the HCR Agreement with HCR, pursuant to which Cara Royalty Sub sold, or agreed to sell, to HCR certain of its rights to receive royalty payments, or the Royalties, due and payable to Cara Royalty Sub (as assignee of the Company) under the Maruishi Agreement and Vifor Agreement No. 2., collectively the Covered License Agreements, in exchange for up to $40,000. The Company has retained all of its right, title and interest in, to and under the Covered License Agreements that relate to any non-intravenous formulation of difelikefalin. Under the terms of the HCR Agreement, Cara Royalty Sub received an upfront payment of $16,915 in November 2023, representing the $17,500 to which the Company was initially entitled, net of advisory fees and certain of HCR’s transaction-related expenses which the Company agreed to reimburse. In December 2023, Cara Royalty Sub received an additional payment of